NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to providing high-quality chemical compounds essential for medical and scientific research, including Phenylacetylglutamine (CAS 28047-15-6). This compound holds significant importance in the study of renal health and the management of urea cycle disorders.

Phenylacetylglutamine is a metabolite formed from the conjugation of phenylacetate and glutamine. It plays a critical role in the body's nitrogen waste removal system, acting as an alternative pathway to the urea cycle, which is essential for individuals with impaired urea synthesis. The compound's involvement in phenylacetylglutamine urea cycle support makes it a key area of study for metabolic disorders.

Emerging research increasingly points to Phenylacetylglutamine as a valuable phenylacetylglutamine kidney disease indicator. Studies have shown that elevated levels of this metabolite in urine can be associated with chronic kidney disease (CKD) and overall renal decline. This makes it a promising non-invasive biomarker for monitoring kidney function and potentially predicting the progression of kidney-related ailments. The analysis of phenylacetylglutamine in human urine is therefore crucial for early diagnosis and management.

Beyond its role in kidney health, Phenylacetylglutamine is also recognized for its association with metabolic age. As individuals age, the composition of their gut microbiota and metabolic processes can change, leading to altered levels of circulating metabolites like Phenylacetylglutamine. The compound serves as a biomarker for metabolic age, offering insights into the biological aging process.

For researchers and medical professionals, understanding the dynamics of Phenylacetylglutamine is paramount. NINGBO INNO PHARMCHEM CO.,LTD. supplies this compound to facilitate critical research, enabling a deeper understanding of its implications in renal health, metabolic processes, and urea cycle disorders. Our commitment to quality ensures that researchers have access to reliable Phenylacetylglutamine for their studies, contributing to advancements in diagnostics and therapeutics.